Nevertheless, the concomitant dysregulation of proteins belonging to the dystroglycan complex (such as sarcoglycans) support the concept of a pathogenicity of the identified inversion and along this line suggest a vulnerability in the overall dystroglycan complex, a known myopathological hallmark in DMD. The gene discussed is DAG1; the disease is Duchenne muscular dystrophy.